Skip to main content
Clinical Trials/CTRI/2025/09/094929
CTRI/2025/09/094929Not yet recruitingNot Applicable

Efficacy of Dry Cupping Therapy in Avabahuka: A Randomised Control Trial

Dr. Gaurav Prakash Londhe1 site in 1 country90 target enrollmentStarted: October 1, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
1.Change in SPADI

Study Overview

Brief Summary

Shoulder joint is the most mobile joint of human body with wide range of movements facilitating day to day work ranging from simple jobs like wearing clothes to complex ones like lifting objects. Imagine cessation of movement of our shoulder joint, attributed further by pain and stiffness. Routine life will be partially handicapped in this scenario. The clinical vignette described above goes by the name of Frozen Shoulder or Adhesive Capsulitis. It is most commonly associated with patients with Diabetes Mellitus. The prevalence of frozen shoulder is estimated to be 2 to 5 percent of the general population. Such patients have a lifetime risk of 10-20 percent of developing frozen shoulder.  Alternatively Supraspinatus Tendinitis also brings similar picture in front of us.Treatment of the above disease in early stage is with analgesics, intraextra capsular corticosteroid injections, which are hepatotoxic, nephrotoxic; produce gastric irritation. It also requires regular ‘pendulum’ exercises of the arm to prevent the capsule from over tightening. So, the patient has to go to physiotherapist for regular follow ups, which is too costly and time consuming. Acharya Sushruta has mentioned the symptom complex analogous to frozen shoulder/supraspinatus tendinitis in Avabahuka.  He opines the use of Raktamokshana in the management of Avabahuka. Raktamokshana has been described as “Ardha Chikitisa” by Acharya Sushruta. It provides quick relief in conditions of shoola (pain) and Shoth (Inflammation). There are various techniques of performing Raktamokshana out of which the technique of choice for the management of Avabahuka is Cupping Therapy. Shringa Therapy can be considered analogous to cupping therapy since vacuum created by suction to draw out blood is mainstay of the modus operandi of both the techniques. This is similar to Wet Cupping therapy. Similarly, Dry cupping can also be performed on the grounds that the ecchymosis thus created by negative pressure can be compared to Raktamokshana. Cupping Therapy has now 4 4 become a mainstay of Sports medicine and being utilized by even top Athletes like Michael Phelps. Chronic conditions like Avabahuka usually do not respond positively to standard protocol of management. Physiotherapy requires additional resources viz. time, money and patience. Raktamokshana is unchartered territory in the arena of Avabahuka management which require to be tapped in and researched upon to give low cost, safe and time bound remedy to its hold on our society. Study plan: Two groups, interventional involves dry cupping and control involves wet cupping therapy. 45 patients sample size per group. Follow up on day 15 and day 30. objective criteria involves range of motion and VAS.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients diagnosed as Avabahuka.
  • (Rotator Cuff tendinopathy and Adhesive capsulitis).
  • Patients of any sex.
  • Patients of age group 20-60 years.
  • Patients irrespective of caste, religion, economical status.

Exclusion Criteria

  • 1.Patient suffering from major trauma having dislocation or fracture at shoulder region.
  • 2.Patient suffering from any major systemic disorders excluding well controlled Diabetes Mellitus-type 2 (BSL-PP less than 200 mg per dl)
  • Those patients who need other emergency interventions like surgery and other means are excluded.
  • HIV, HBsAg positive patients are also excluded.
  • Patient suffering from Haematological disorders like thrombocytopenia, Von Willebrand’s disease, thalassemia etc.
  • Patient suffering from severe Anaemia (Hb less than 8 gm percent).

Outcomes

Primary Outcomes

1.Change in SPADI

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

(Shoulder Pain and Disability Index) total

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

score from baseline to day 30.

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

2.Shoulder ROM (abduction, flexion, external

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

rotation) using goniometer.

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

3.VAS (Visual Analogue Scale) for pain at rest

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

and on movement.

Time Frame: 1. Baseline (Day 0), Week 6 (end of treatment | plus or minus 3 days). | 2.Baseline, Week 2, Week 4, Week 6, Week | 12. | 3.Baseline, Week 2, Week 4, Week 6, Week | 12 | chronologically.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr. Gaurav Prakash Londhe
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Gaurav Prakash Londhe

RA Podar Medical College.

Study Sites (1)

Loading locations...

Similar Trials